SCHEMBL23811151

SCHEMBL23811151

CCCCCCCC(C)N1C(=O)C=C(C)C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
PKM P14618 1/20 0.40
HTT P42858 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SHMT2 P34897 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP2C19 P33261 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
PTGS1 P23219 3/20 0.36
PTGS2 P35354 3/20 0.36
MGLL Q99685 3/20 0.36
FAAH O00519 1/20 0.36
POLB P06746 1/20 0.33
GPR84 Q9NQS5 1/20 0.32
ADH1B P00325 1/20 0.32
ADH1C P00326 1/20 0.32
ADH1A P07327 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21114780 0.81 ACHE (0.41) SMN1; SMN2LMNAPKMHTTHSD17B10
SCHEMBL14493752 0.79 POLB (0.32) SMN1; SMN2HTTALDH1A1MEN1KMT2A
SCHEMBL6937953 0.79 GPR84 (0.40) SMN1; SMN2LMNAHSD17B10ALDH1A1POLB
SCHEMBL3482625 0.78 MGLL (0.50) SMN1; SMN2LMNAPKMHTTHSD17B10
SCHEMBL3482787 0.75 MGLL (0.47) SMN1; SMN2LMNAPKMHTTHSD17B10
SCHEMBL14493740 0.74 TSHR (0.32)
SCHEMBL29257418 0.72 TDP1 (0.54) LMNAALDH1A1MEN1KMT2ANPSR1
SCHEMBL30423475 0.72 TDP1 (0.54) LMNAALDH1A1MEN1KMT2ANPSR1
SCHEMBL6941606 0.72 PTPN1 (0.41) HSD17B10ALDH1A1POLBPTPN1
SCHEMBL18504935 0.71 SMN1; SMN2 (0.37) SMN1; SMN2LMNAPKMHTTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210285955-A1 METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES WARP DRIVE BIO, INC. 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210285955-A1 METHODS AND REAGENTS FOR ANALYZING PROTEIN-PROTEIN INTERFACES FKBP8, PIN1, FKBP1A SMN1; SMN2 4204/4885LMNA 3566/4885PKM 3438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.